PSMA PET/CT-targeted biopsy improves detection of clinically significant prostate cancer
PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with negative or inconclusive MRI findings but persistent clinical risk factors. According to new research published in The Journal of Nuclear Medicine, combining the two biopsy approaches is even more effective, nearly doubling the detection rate. This strategy may help physicians…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
About 13% of newly qualified nurses and midwives leave hospital work within six years
United Kingdom
-
New guidance outlines how to protect people living with heart disease during heat waves
United Kingdom
-
Autonomous AI can increase clinical capacity for dermatologists
United Kingdom
-
Blood flow directs signals that assign liver cells their jobs, mouse study finds
United Kingdom
-
Of mice and zebrafish: How scientists solved a decades-old mystery and uncovered new insights about inflammation
United Kingdom
-
Approved cancer drug may reduce kidney damage linked to nail-patella syndrome
United Kingdom
-
Before saying yes to the medical test, know the risks and benefits
United Kingdom
-
Blood marker may flag Alzheimer's-related changes in Down syndrome decades before symptoms appear
United Kingdom